CKB and hepatocellular carcinoma: Of all 11 models validated in the general population, Li-2018 and Wen 1–2012 had good discrimination for 10-year HCC, while CLivD score (non-lab and lab) and dAAR had the highest discrimination for 10-year CLD in CKB.